Suppr超能文献

伊朗老年人多种疾病的决定因素:一项基于布什尔老年人健康(BEH)项目使用潜在类别分析的横断面研究。

Determinants of multimorbidity in older adults in Iran: a cross-sectional study using latent class analysis on the Bushehr Elderly Health (BEH) program.

作者信息

Marzban Maryam, Jamshidi Ali, Khorrami Zahra, Hall Marlous, Batty Jonathan A, Farhadi Akram, Mahmudpour Mehdi, Gholizade Mohamad, Nabipour Iraj, Larijani Bagher, Afrashteh Sima

机构信息

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, QLD, Brisbane, Australia.

The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.

出版信息

BMC Geriatr. 2024 Mar 11;24(1):247. doi: 10.1186/s12877-024-04848-y.

Abstract

BACKGROUND AND OBJECTIVES

Multimorbidity, defined as the presence of two or more long-term health conditions in an individual, is one of the most significant challenges facing health systems worldwide. This study aimed to identify determinants of classes of multimorbidity among older adults in Iran.

RESEARCH DESIGN AND METHODS

In a cross-sectional sample of older adults (aged ≥ 60 years) from the second stage of the Bushehr Elderly Health (BEH) program in southern Iran, latent class analysis (LCA) was used to identify patterns of multimorbidity. Multinomial logistic regression was conducted to investigate factors associated with each multimorbidity class, including age, gender, education, household income, physical activity, smoking status, and polypharmacy.

RESULTS

In 2,426 study participants (mean age 69 years, 52% female), the overall prevalence of multimorbidity was 80.2%. Among those with multimorbidity, 3 latent classes were identified. These comprised: class 1, individuals with a low burden of multisystem disease (56.9%); class 2, individuals with predominantly cardiovascular-metabolic disorders (25.8%) and class 3, individuals with predominantly cognitive and metabolic disorders (17.1%). Compared with men, women were more likely to belong to class 2 (odds ratio [OR] 1.96, 95% confidence interval [CI] 1.52-2.54) and class 3 (OR 4.52, 95% CI 3.22-6.35). Polypharmacy was associated with membership class 2 (OR 3.52, 95% CI: 2.65-4.68) and class 3 (OR 1.84, 95% CI 1.28-2.63). Smoking was associated with membership in class 3 (OR 1.44, 95% CI 1.01-2.08). Individuals with higher education levels (59%) and higher levels of physical activity (39%) were less likely to belong to class 3 (OR 0.41; 95% CI: 0.28-0.62) and to class 2 (OR 0.61; 95% CI: 0.38-0.97), respectively. Those at older age were less likely to belong to class 2 (OR 0.95).

DISCUSSION AND IMPLICATIONS

A large proportion of older adults in Iran have multimorbidity. Female sex, polypharmacy, sedentary lifestyle, and poor education levels were associated with cardiovascular-metabolic multimorbidity and cognitive and metabolic multimorbidity. A greater understanding of the determinants of multimorbidity may lead to strategies to prevent its development.

摘要

背景与目的

多病共存定义为个体存在两种或更多种长期健康状况,是全球卫生系统面临的最重大挑战之一。本研究旨在确定伊朗老年人中多病共存类型的决定因素。

研究设计与方法

在伊朗南部布什尔老年人健康(BEH)项目第二阶段的老年人(年龄≥60岁)横断面样本中,采用潜在类别分析(LCA)来确定多病共存模式。进行多项逻辑回归以研究与每种多病共存类别相关的因素,包括年龄、性别、教育程度、家庭收入、身体活动、吸烟状况和多重用药情况。

结果

在2426名研究参与者(平均年龄69岁,52%为女性)中,多病共存的总体患病率为80.2%。在那些患有多病共存的人群中,确定了3种潜在类别。这些类别包括:第1类,多系统疾病负担低的个体(56.9%);第2类,主要患有心血管 - 代谢紊乱的个体(25.8%);第3类,主要患有认知和代谢紊乱的个体(17.1%)。与男性相比,女性更有可能属于第2类(优势比[OR]1.96,95%置信区间[CI]1.52 - 2.54)和第3类(OR 4.52,95%CI 3.22 - 6.35)。多重用药与第2类(OR 3.52,95%CI:2.65 - 4.68)和第3类(OR 1.84,95%CI 1.28 - 2.63)的类别归属相关。吸烟与第3类的类别归属相关(OR 1.44,95%CI 1.01 - 2.08)。教育水平较高(59%)和身体活动水平较高(39%)的个体分别不太可能属于第3类(OR 0.41;95%CI:0.28 - 0.62)和第2类(OR 0.61;95%CI:0.38 - 0.97)。年龄较大的个体不太可能属于第2类(OR 0.95)。

讨论与启示

伊朗很大一部分老年人患有多病共存。女性、多重用药、久坐不动的生活方式和低教育水平与心血管 - 代谢性多病共存以及认知和代谢性多病共存相关。对多病共存决定因素的更深入了解可能会带来预防其发展的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ca/10929162/9ad6b25bae69/12877_2024_4848_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验